β-hydroxybutyrate suppresses pathological changes of blood-induced arthropathy in rats
Arthropathy is a common complication in haemophilia and decreases quality of life. It has been known that concentrations of β-hydroxybutyrate (BHB) in blood are increased by a ketogenic diet, and elevated levels of circulating BHB restricts the progression of inflammation-mediated joint pathological changes. We hypothesized that elevation of blood BHB concentrations could be effective for reducing the progression of bleeding-induced arthropathy by moderating the inflammatory responses of macrophages. In this study, we investigated whether BHB alleviates the arthropathy caused by repeated intra-articular blood injection in rats. To increase blood BHB levels, rats were fed with ketogenic diet. Repeated intra-articular blood injection induced significant joint swelling, whereas ketogenic diet intake significantly increased blood BHB concentrations and ameliorated the joint swelling. The periarticular tissue-fibrosis observed in the control diet intake group appeared to be significantly alleviated in the ketogenic diet intake group. In addition, the IL-1β, which is involved in the progression of arthropathy, levels in the supernatants of blood-exposed macrophages derived from THP-1 cell line were significantly suppressed by BHB supplementation. In summary, BHB moderated the pathological joint changes caused by intra-articular blood exposure.
Authors
- Maiko Takeda (ORCID: https://orcid.org/0000-0002-1185-4613)
- Midori Shima (ORCID: https://orcid.org/0000-0002-5922-7061)
- Asuka Sakata (ORCID: https://orcid.org/0000-0001-7144-001X)
- Ryohei Kawasaki (ORCID: https://orcid.org/0000-0002-0821-2855)
- Shogo Kasuda (ORCID: https://orcid.org/0000-0001-8527-8367)
- Kohei Tatsumi (ORCID: https://orcid.org/0000-0002-4732-1093)
- Yasushi Yoshimura (ORCID: https://orcid.org/0000-0003-2027-1257)
- Tetsuhiro Soeda
- Naoki Matsumoto (ORCID: https://orcid.org/0000-0001-7903-6820)
- Yukiko Nishida
- Seiji Mitani (ORCID: https://orcid.org/0000-0002-1348-0774)
- Suguru Harada
Institutions
- Chugai Pharma (United States) (US)
- Nara Medical University (JP)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1038/s41598-024-77074-6
- Citations
- 1
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- Chugai Pharmaceutical